Orthopediatrics Corp financial data

Symbol
KIDS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2850 Frontier Drive, Warsaw, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 540 % -5.2%
Quick Ratio 282 % +25.9%
Debt-to-equity 20.6 % +44.1%
Return On Equity -7.64 % -30%
Return On Assets -6.34 % -23.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24.2M shares +3.69%
Common Stock, Shares, Outstanding 23.4M shares +2.19%
Entity Public Float 445M USD -5.6%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 23.2M shares +1.79%
Weighted Average Number of Shares Outstanding, Diluted 23.2M shares +1.79%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 190M USD +33.5%
Research and Development Expense 10.3M USD +3.34%
Selling and Marketing Expense 58.9M USD +15.5%
General and Administrative Expense 99.5M USD +40.6%
Operating Income (Loss) -29M USD -7.51%
Nonoperating Income (Expense) -3.4M USD -173%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.4M USD -45.4%
Income Tax Expense (Benefit) -3.98M USD -243%
Net Income (Loss) Attributable to Parent -28.4M USD -28.5%
Earnings Per Share, Basic -1.23 USD/shares -28.1%
Earnings Per Share, Diluted -1.23 USD/shares -29.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51M USD +380%
Accounts Receivable, after Allowance for Credit Loss, Current 42.8M USD +13.8%
Inventory, Net 121M USD +20.3%
Assets, Current 248M USD +9.79%
Property, Plant and Equipment, Net 54.8M USD +36.1%
Operating Lease, Right-of-Use Asset 6.94M USD +1296%
Goodwill 91.3M USD +12.8%
Other Assets, Noncurrent 10.3M USD +1552%
Assets 489M USD +13.1%
Accounts Payable, Current 11.6M USD -48.4%
Employee-related Liabilities, Current 13.2M USD +52.5%
Liabilities, Current 34.6M USD -27.8%
Deferred Income Tax Liabilities, Net 4.03M USD -26.7%
Other Liabilities, Noncurrent 4.8M USD +762%
Liabilities 118M USD +104%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.6M USD +45.7%
Retained Earnings (Accumulated Deficit) -219M USD -14.9%
Stockholders' Equity Attributable to Parent 371M USD -0.91%
Liabilities and Equity 489M USD +13.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.69M USD -3.54%
Net Cash Provided by (Used in) Financing Activities -573K USD -1492%
Net Cash Provided by (Used in) Investing Activities -3.68M USD -111%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 24.2M shares +3.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.46M USD -137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 53M USD +334%
Interest Paid, Excluding Capitalized Interest, Operating Activities 223K USD +1927%
Deferred Tax Assets, Valuation Allowance 41.9M USD +14%
Deferred Tax Assets, Gross 52.8M USD +9.33%
Operating Lease, Liability 6.57M USD +1414%
Payments to Acquire Property, Plant, and Equipment 6.46M USD +30.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -22.9M USD +15.9%
Property, Plant and Equipment, Gross 80.6M USD +23.9%
Deferred Income Tax Expense (Benefit) -2.45M USD -326%
Deferred Tax Assets, Operating Loss Carryforwards 42.2M USD +9.77%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 597M USD +3.37%
Depreciation, Depletion and Amortization 5.03M USD +30.7%
Deferred Tax Assets, Net of Valuation Allowance 10.8M USD -5.62%